This is a $19,271.70 firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Irepertoire Inc., a self-certified small disadvantaged business. The contract is for immune repertoire sequencing services, with a completion date of July 8, 2024. Irepertoire Inc. has previously provided similar services to various HHS and Department of Veterans Affairs (VA)...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Irepertoire Inc., a self-certified small disadvantaged business. The $6,580 firm-fixed-price purchase order is for IPAIR Collaboration and Data Analysis Services, which likely involve T-cell receptor sequencing, RNA sequencing, PCR amplification, and related laboratory testing to support NIAID's research and...
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Irepertoire Inc., a self-certified small disadvantaged business, for $61,965.00. The contract is for the delivery of IPAIR-REAGENTS, A2S-IPAIR, A2S-MI-V2, and IPAIR CAPTURE PLATE items, with data included at no additional cost. This purchase order is related to a prior pre-solicitation notice for a sole-source requirement...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to Irepertoire Inc., a self-certified small disadvantaged business, for PCR amplification services and sequencing services. The contract has a ceiling value of $22,932.00 and a period of performance through December 31, 2024. Irepertoire Inc. specializes in immune repertoire sequencing services, including T-cell receptor sequencing, to support research and...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Irepertoire Inc., a small disadvantaged business, for T-cell receptor sequencing services. The contract has a potential value of $19,404.00 and a completion date of July 26, 2024. Irepertoire Inc. has previously provided a range of services to HHS and other federal agencies, including T-cell receptor...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Irepertoire Inc., a small disadvantaged business, for RNA sequencing services for mouse T cell receptor research. The contract has a total ceiling value of $13,230.00 and a period of performance through February 28, 2025. Irepertoire Inc. will provide services such as T-cell receptor sequencing,...
Irepertoire Inc. was awarded a $19,620 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide T cell receptor deep sequencing services. The contract has a period of performance through May 10, 2024 and was awarded on January 11, 2024 without a set-aside designation. As part of its mission to understand, treat, and ultimately prevent infectious, immunologic, and allergic...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order to Adaptive Biotechnologies Corporation, doing business as Adaptive, for $37,820.00. The contract is for immunosequencing services, including T-cell receptor alpha/delta (TCRA/D) and B-cell repertoire (HSTCRB) sequencing, to analyze diversity of these cells in primary immunodeficiency research. The award...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, for ILLUMINA ISEQ 100 I1 REAGENT. The potential value of this contract is $9,991.97. This award is not associated with any larger contract vehicle and does not have a set-aside designation. Illumina has previously provided sequencing systems, reagents,...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $241,046.40 firm fixed-price purchase order to Illumina, Inc. to provide reagents and supplies. The award has no set-aside designation. Illumina is a manufacturer and provider of genetic sequencing instruments and analytical products. This award aligns with Illumina's past prime federal contracts to support genomic sequencing and analysis for various government agencies including the CDC,...